Teva Pharmaceutical Industries Aktie

Kaufen
Verkaufen
14,95 EUR -1,55 EUR -9,39 %
16,73 USD -0,03 USD -0,18 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN 883035

ISIN US8816242098

Symbol TEVA


Teva Pharmaceutical Industries Aktie Analyse

04.05.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
23.04.12 Teva Pharmaceutical Industries buy UBS AG
06.03.12 Teva Pharmaceutical Industries buy UBS AG
16.02.12 Teva Pharmaceutical Industries buy UBS AG
07.12.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
01.12.11 Teva Pharmaceutical Industries buy UBS AG
09.11.11 Teva Pharmaceutical Industries outperform Credit Suisse Group
04.11.11 Teva Pharmaceutical Industries overweight Morgan Stanley
03.11.11 Teva Pharmaceutical Industries buy UBS AG
03.11.11 Teva Pharmaceutical Industries strong buy Needham & Company, LLC
01.11.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
25.10.11 Teva Pharmaceutical Industries buy Citigroup Corp.
06.10.11 Teva Pharmaceutical Industries buy Citigroup Corp.
05.10.11 Teva Pharmaceutical Industries buy UBS AG
31.08.11 Teva Pharmaceutical Industries buy Citigroup Corp.
19.08.11 Teva Pharmaceutical Industries outperform Leerink Swann LLC
18.08.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
03.08.11 Teva Pharmaceutical Industries buy UBS AG
03.08.11 Teva Pharmaceutical Industries buy UBS AG
29.07.11 Teva Pharmaceutical Industries outperform RBC Capital Markets
28.07.11 Teva Pharmaceutical Industries buy UBS AG
26.07.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
19.07.11 Teva Pharmaceutical Industries buy Citigroup Corp.
23.05.11 Teva Pharmaceutical Industries kaufen Die Actien-Börse
17.05.11 Teva Pharmaceutical Industries buy Citigroup Corp.
12.05.11 Teva Pharmaceutical Industries buy UBS AG
06.05.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
03.05.11 Teva Pharmaceutical Industries buy UBS AG
26.04.11 Teva Pharmaceutical Industries buy UBS AG
13.04.11 Teva Pharmaceutical Industries overweight Barclays Capital
07.04.11 Teva Pharmaceutical Industries overweight Barclays Capital
28.03.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
28.03.11 Teva Pharmaceutical Industries overweight Barclays Capital
21.03.11 Teva Pharmaceutical Industries overweight Barclays Capital
09.02.11 Teva Pharmaceutical Industries buy UBS AG
09.02.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
08.02.11 Teva Pharmaceutical Industries overweight Barclays Capital
03.02.11 Teva Pharmaceutical Industries buy UBS AG
02.02.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
26.01.11 Teva Pharmaceutical Industries buy UBS AG
21.12.10 Teva Pharmaceutical Industries overweight Barclays Capital
10.12.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
27.10.10 Teva Pharmaceutical Industries overweight Barclays Capital
25.10.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
19.10.10 Teva Pharmaceutical Industries overweight Barclays Capital
10.09.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
09.09.10 Teva Pharmaceutical Industries outperform Oppenheimer & Co. Inc.
19.08.10 Teva Pharmaceutical Industries buy Citigroup Corp.
03.08.10 Teva Pharmaceutical Industries overweight Barclays Capital
02.08.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
Werbung